CC
Casdin Capital Portfolio holdings
AUM
$1.1B
This Quarter Return
-22.35%
1 Year Return
+24.98%
3 Year Return
+152.8%
5 Year Return
+110.01%
10 Year Return
–
AUM
$84.5M
AUM Growth
+$84.5M
(-21%)
Cap. Flow
+$6.47M
Cap. Flow
% of AUM
7.66%
Top 10 Holdings %
Top 10 Hldgs %
68.91%
Holding
33
New
5
Increased
12
Reduced
6
Closed
7
Top Buys
| 1 |
FMI
Foundation Medicine, Inc.
FMI
|
$4M |
| 2 |
Editas Medicine
EDIT
|
$2.95M |
| 3 |
EPZM
Epizyme, Inc
EPZM
|
$2.58M |
| 4 |
Agios Pharmaceuticals
AGIO
|
$2.09M |
| 5 |
KITE
Kite Pharma, Inc.
KITE
|
$2.07M |
Top Sells
| 1 |
Illumina
ILMN
|
$5.76M |
| 2 |
GHDX
Genomic Health, Inc.
GHDX
|
$2.72M |
| 3 |
GNMK
GenMark Diagnostics, Inc
GNMK
|
$2.41M |
| 4 |
NVTA
Invitae Corporation
NVTA
|
$2.05M |
| 5 |
BPMC
Blueprint Medicines
BPMC
|
$1.65M |
Sector Composition
| 1 | Healthcare | 87.92% |
| 2 | Industrials | 0.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
LOXO
1
DELISTED
Loxo Oncology, Inc
LOXO
| $6.84M | 7.85% | 250,000 -1,500 | -0.6% | -$41K |
|
|
EPZM
2
DELISTED
Epizyme, Inc
EPZM
| $6.61M | 7.58% | 545,000 +212,500 | +64% | +$2.58M |
|
|
FMI
3
DELISTED
Foundation Medicine, Inc.
FMI
| $6.09M | 6.99% | 335,000 +220,000 | +191% | +$4M |
|
|
SAGE
4
DELISTED
Sage Therapeutics
SAGE
| $6.06M | 6.95% | 189,000 +45,989 | +32% | +$1.47M |
|
|
5
Agios Pharmaceuticals
AGIO
$2.19B
| $6.01M | 6.9% | 148,000 +51,500 | +53% | +$2.09M |
|
|
BPMC
6
DELISTED
Blueprint Medicines
BPMC
| $5.8M | 6.66% | 321,300 -91,200 | -22% | -$1.65M |
|
7
Alnylam Pharmaceuticals
ALNY
$58.5B
| $5.65M | 6.48% | 90,000 +30,000 | +50% | +$1.88M |
|
|
BLUE
8
DELISTED
bluebird bio
BLUE
| $5.1M | 5.85% | 120,000 +20,000 | +20% | +$850K |
|
|
MYOK
9
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $5.09M | 5.84% | 475,350 +71,478 | +18% | +$766K |
|
|
ONCE
10
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $5.02M | 5.76% | 170,000 +25,000 | +17% | +$738K |
|
11
CytomX Therapeutics
CTMX
$336M
| $4.14M | 4.75% | 321,023 | – | – |
|
|
KITE
12
DELISTED
Kite Pharma, Inc.
KITE
| $3.44M | 3.95% | 75,000 +45,000 | +150% | +$2.07M |
|
13
Voyager Therapeutics
VYGR
$186M
| $2.96M | 3.4% | 339,362 +102,500 | +43% | +$895K |
|
|
14
Editas Medicine
EDIT
$231M
| $2.95M | 3.39% | +85,470 | New | +$2.95M |
|
15
DexCom
DXCM
$29.5B
| $2.72M | 3.12% | 40,000 +23,000 | +135% | +$1.56M |
|
|
AVXS
16
DELISTED
AveXis, Inc. Common Stock
AVXS
| $1.72M | 1.97% | +63,000 | New | +$1.72M |
|
|
GBT
17
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $1.67M | 1.91% | 105,000 +40,000 | +62% | +$634K |
|
|
GHDX
18
DELISTED
Genomic Health, Inc.
GHDX
| $1.36M | 1.56% | 55,000 -110,000 | -67% | -$2.72M |
|
19
Bristol-Myers Squibb
BMY
$96B
| $1.34M | 1.54% | 21,000 -11,164 | -35% | -$713K |
|
20
Biogen
BIIB
$19.4B
| $1.3M | 1.49% | 5,000 -4,000 | -44% | -$1.04M |
|
|
ONC
21
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $953K | 1.09% | +32,500 | New | +$953K |
|
|
RXDX
22
DELISTED
Ignyta, Inc.
RXDX
| $745K | 0.86% | +110,000 | New | +$745K |
|
23
Exact Sciences
EXAS
$8.98B
| $404K | 0.46% | +60,000 | New | +$404K |
|
|
MDSO
24
DELISTED
Medidata Solutions, Inc.
MDSO
| $387K | 0.44% | 10,000 | – | – |
|
|
OXFD
25
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $198K | 0.23% | 20,000 -55,000 | -73% | -$545K |
|